Published in
Cell Press, Molecular Therapy - Oncolytics, (20), p. 459-469, 2021
DOI: 10.1016/j.omto.2021.02.006
Links
Tools
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform
Journal article published in 2021 by
Erkko Ylösmäki,
Leena Ylösmäki,
Manlio Fusciello 
,
Beatriz Martins,
Petra Ahokas,
Hanne Cojoc,
Arttu Uoti,
Sara Feola,
Anna Kreutzman,
Tuuli Ranki,
Julia Karbach,
Tapani Viitala,
Petri Priha,
Elke Jäger,
Sari Pesonen
and other authors.
,
Beatriz Martins,
Petra Ahokas,
Hanne Cojoc,
Arttu Uoti,
Sara Feola,
Anna Kreutzman,
Tuuli Ranki,
Julia Karbach,
Tapani Viitala,
Petri Priha,
Elke Jäger,
Sari Pesonen
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 